Vontobel Swiss Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$8.11M Buy
123,928
+5,582
+5% +$364K 4.17% 6
2021
Q1
$7.47M Buy
118,346
+26,183
+28% +$1.63M 4.17% 6
2020
Q4
$5.72M Sell
92,163
-394
-0.4% -$24.2K 3.25% 16
2020
Q3
$5.42M Buy
92,557
+4,720
+5% +$284K 3.79% 12
2020
Q2
$5.17M Buy
87,837
+10,494
+14% +$628K 3.39% 10
2020
Q1
$4.31M Sell
77,343
-211
-0.3% -$12.9K 3.28% 8
2019
Q4
$4.98M Buy
77,554
+10,140
+15% +$581K 3.25% 4
2019
Q3
$3.42M Sell
67,414
-6,471
-9% -$304K 2.2% 12
2019
Q2
$3.35M Buy
+73,885
New +$3.44M 1.8% 22

Other funds holding BMY

Vontobel Swiss Wealth Advisors's BMY Position: Q2 2021 in Review

Vontobel Swiss Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 4.7% in Q2 2021, buying an estimated $364K and bringing the position to 123,928 shares worth $8.11M. The position accounts for 4.17% of the portfolio, ranked #6.

Vontobel Swiss Wealth Advisors first reported a position in BMY in Q2 2019 and has held it in 9 quarters since. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Vontobel Swiss Wealth Advisors held 123,928 shares of Bristol-Myers Squibb worth $8.11M as of Q2 2021.
  • Vontobel Swiss Wealth Advisors bought 5,582 Bristol-Myers Squibb shares in Q2 2021, an estimated $364K.
  • Bristol-Myers Squibb made up 4.17% of Vontobel Swiss Wealth Advisors's portfolio in Q2 2021, its #6 holding.
  • Vontobel Swiss Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 9 quarters since.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Vontobel Swiss Wealth Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.